Weight loss drugs linked to dozens of deaths as NHS warns about side effects

dailyrecord.co.uk:

The number of drug-related fatalities in the UK linked to diabetes and weight loss medications has risen to 82, according to new data from the Medicines and Healthcare Products Regulatory Agency (MHRA).

The figures, updated to January 31, revealed the increasing death toll associated with GLP-1RA receptor agonist drugs. Among the reported deaths, 22 individuals were using these medications for weight loss, a significant increase from 10 deaths recorded in October, highlighting the growing popularity of these treatments.These drugs are primarily prescribed for either type 2 diabetes management, weight loss, or both.

Tirzepatide, marketed as Mounjaro, was initially approved for diabetes treatment but was later authorised for weight management.

Semaglutide, on the other hand, is available under different brand names, such as Wegovy, which is licensed for managing obesity.